The news is that they've 'accelerated' the timeline by pushing back commercialisation by a further 12 months.
That's assuming that the 18 month clinical phase which now appears to be 6 months doesn't also need adjustments further down the line.
No news would have been good news in this case I'm afraid.
Back in the bottom drawer for this one.
Ann: AGM Presentation, page-15
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
59.5¢ |
Change
0.005(0.85%) |
Mkt cap ! $65.61M | |||
| Open | High | Low | Value | Volume |
| 59.5¢ | 59.5¢ | 59.5¢ | $3.887K | 6.533K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3467 | 59.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 60.0¢ | 5000 | 1 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |